| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.027 | 0.6 |